Helus Pharma Highlights Clinical Program Advancements at Investor Presentation Held on October 21, 2026
Topline data readout from APPROACH Phase 3 study of HLP003 in development for the potential adjunctive treatment of major depressive...
Clinical Trial
Cardiff Oncology Receives FDA Orphan Drug Designation for Onvansertib in Chronic Myelomonocytic Leukemia
SAN DIEGO, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cardiff Oncology, Inc. (Nasdaq: CRDF), a clinical-stage biotechnology company leveraging PLK1 inhibition...
Cytokinetics to Announce Third Quarter Results on November 4, 2026
SOUTH SAN FRANCISCO, Calif., Oct. 21, 2026 (GLOBE NEWSWIRE) -- Cytokinetics, Incorporated (Nasdaq: CYTK) today announced that it is scheduled...
Ensysce Biosciences Expands Global Investor and Strategic Outreach at Family Office Summit, Dubai
~President James Morrison met Middle East family offices as Ensysce advances CY200 and its severe pain pipeline~ SAN DIEGO, CA...
Valion Bio’s New Leadership Unveils 30-Day Agenda to Accelerate Clinical Pipeline and Unlock Shareholder Value
Interim CEO Dean Zikria's initial review prioritizes Entolimod and pipeline advancement, commercialization of Velocity Bioworks, and strategic opportunities to maximize...
Omre NMN + Resveratrol Posts the Highest NMN Purity in Independent Testing, and 1,500+ Reviews Back It Up
Doctor-developed, over-99%-pure NMN with 500 mg of micronized resveratrol, tested twice by independent labs and rated 4.7 out of 5...
NRG Therapeutics Announces a PET Biodistribution Trial of Lead Clinical Asset NRG5051
STEVENAGE, United Kingdom, Oct. 21, 2026 (GLOBE NEWSWIRE) -- NRG Therapeutics Ltd. (“NRG”), an innovative clinical stage neuroscience company targeting...
Avance Clinical to Meet European Biotechs at ESMO Congress 2026 and Appoints Wendy Hamon as Senior Vice President, Oncology Center of Excellence
Executive Medical Director Dr George Peoples to discuss oncology programs from preclinical through Phase II in Madrid Wendy Hamon Wendy...
First Patient Treated in the C-FLASH-01 ConformalFLASH® Clinical Trial
First Patient Treated in the C-FLASH-01 ConformalFLASH® Clinical Trial Louvain-la-Neuve, Belgium, October 21, 2026 – IBA (Ion Beam Applications S.A.,...
F2G and Shionogi Report Data from Global Phase 3 OASIS Study Evaluating Investigational Oral Olorofim Versus AmBisome® Followed by Standard of Care in Invasive Aspergillosis in Late-Breaking Oral Presentation at IDWeek 2026
Oral olorofim was non-inferior to AmBisome® followed by standard of care (AmBisome®+SOC), with Day 42 all-cause mortality of 23.8% for...
HUTCHMED Announces Closing of KRAS-EGFR-Antibody Conjugate Therapy License to GSK Outside China
HONG KONG, SHANGHAI and FLORHAM PARK, N.J., Oct. 20, 2026 (GLOBE NEWSWIRE) -- HUTCHMED (China) Limited (“HUTCHMED” or the “Company”)...
Telix Reports Third Quarter 2026 Financial Performance
MELBOURNE, Australia and INDIANAPOLIS, Oct. 21, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) provides a...
BioSyent to Present at Planet MicroCap Toronto
MISSISSAUGA, Ontario, Oct. 20, 2026 (GLOBE NEWSWIRE) -- BioSyent Inc. (“BioSyent”, TSX Venture: RX) is pleased to announce that it...
Surrozen Announces Closing of Second Tranche of March 2025 Private Placement for $95.1 Million
Proceeds strengthen balance sheet and provide expected cash runway into 2029 to advance SZN-8141 and SZN-8143SOUTH SAN FRANCISCO, Calif., Oct....
Azra AI Acquires Blackford Analysis to Close the Most Dangerous Gap in Healthcare: What Happens After the Scan
One platform now carries every imaging finding from the first scan to completed care, ending the era of AI flags...
CHICAGO VENTURE SUMMIT LAUNCHES FUTURE OF HEALTH WITH LARGEST STARTUP PORTFOLIO IN EVENT HISTORY
More than 300 startups and 900 leaders from business, government,healthcare, research, and investment for the summit's first editionfocused exclusively on...
Metabolon Announces New Bioinformatics Application to Translate Metabolomic Biomarkers into Actionable Multiomic Hypotheses
New bioinformatics application combines curated metabolite-protein knowledge, advanced network algorithms, interactive exploration, and optional AI interpretation to generate clearer mechanistic...
Ryght AI and ElixirTrials Partner to Bring End-to-End AI-Powered Trial Workflows to Research Sites Worldwide
Elixir CEO Heather Grey joins Ryght as an advisor to its global study startup operations; partnership will bring site-facing AI...
NanoViricides’ Revolutionary Broad-Spectrum Drug Candidate NV-387 Has Successfully Demonstrated Excellent Indications for Safety and Toxicology in a Juvenile Mouse Pups Animal Study, Paving the Way for Pediatric Use in Clinical Trials
The Spreading Ebola Epidemic as well as Mpox Endemic in Africa Disproportionately Impact Children; The Measles Outbreaks Primarily Impact Children...
Oracle and AstraZeneca Partner to Advance AI-enabled Healthcare Innovation
Collaboration to connect AstraZeneca's scientific and therapeutic expertise with Oracle's real-world data, cloud, AI, and clinical capabilities to accelerate clinical...